Ticker
PHATCompany Name
PHATHOM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 218.88M | $ 91.82M | $ 127.05M |
3/31/2025 | $ 264.9M | $ 74.03M | $ 190.87M |
12/31/2024 | $ 360.13M | $ 85.73M | $ 274.41M |
9/30/2024 | $ 373.82M | $ 65.29M | $ 308.53M |
6/30/2024 | $ 304.79M | $ 47.01M | $ 257.78M |
3/31/2024 | $ 340.31M | $ 43.46M | $ 296.86M |
12/31/2023 | $ 397.43M | $ 38.78M | $ 358.65M |
9/30/2023 | $ 226.73M | $ 23.98M | $ 202.75M |
6/30/2023 | $ 257.72M | $ 21.55M | $ 236.17M |
3/31/2023 | $ 139.84M | $ 14.44M | $ 125.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for PHATHOM PHARMACEUTICALS INC is calculated as follows: AssetsC [ $ 227.16M ] - LiabilitesC [ $ 27.67M ]
(=) Working Capital [ $ 199.49M ]
Minimum
Mar 31, 2023
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 2.79K |
---|---|
min | $ -457.39M |
max | $ 607.04M |
average | $ 96.42M |
median | $ 32.11M |
std | $ 173.65M |